Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Other financing activities (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Other financing activities for 4 consecutive years, with -$25.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other financing activities fell 316.67% year-over-year to -$25.0 million, compared with a TTM value of -$81.0 million through Dec 2025, down 138.24%, and an annual FY2025 reading of -$81.0 million, down 138.24% over the prior year.
  • Other financing activities was -$25.0 million for Q4 2025 at GE HealthCare Technologies, up from -$41.0 million in the prior quarter.
  • Across five years, Other financing activities topped out at $7.0 million in Q1 2024 and bottomed at -$41.0 million in Q3 2025.
  • Average Other financing activities over 4 years is -$16.0 million, with a median of -$17.5 million recorded in 2022.
  • The sharpest move saw Other financing activities surged 116.67% in 2023, then tumbled 1200.0% in 2024.
  • Year by year, Other financing activities stood at -$3.0 million in 2022, then crashed by 733.33% to -$25.0 million in 2023, then surged by 76.0% to -$6.0 million in 2024, then crashed by 316.67% to -$25.0 million in 2025.
  • Business Quant data shows Other financing activities for GEHC at -$25.0 million in Q4 2025, -$41.0 million in Q3 2025, and -$9.0 million in Q2 2025.